Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.

被引：0
|
作者：
Paluri, Ravi Kumar
Li, Peng
Jones, Benjamin Scott
Madan, Ankit
Jerome, Mary
Miley, Debi
Keef, Jennifer
Robert, Francisco
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama, Hoover, AL USA
[3] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Ravi Paluri
    Ankit Madan
    Peng Li
    Benjamin Jones
    Mansoor Saleh
    Mary Jerome
    Deborah Miley
    Jennifer Keef
    Francisco Robert
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 551 - 559
  • [2] Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
    Paluri, Ravi
    Madan, Ankit
    Li, Peng
    Jones, Benjamin
    Saleh, Mansoor
    Jerome, Mary
    Miley, Deborah
    Keef, Jennifer
    Robert, Francisco
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 551 - 559
  • [3] A phase 1b, open label, single institution trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors.
    Madan, Ankit
    Jones, Benjamin Scott
    Paluri, Ravi Kumar
    Jerome, Mary
    Miley, Debi
    Robert, Francisco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] A phase 1b study to evaluate TAK-659 in combination with nivolumab in patients (pts) with advanced solid tumors.
    Juric, Dejan
    Faucette, Stephanie
    Wang, Ling
    Niu, Huifeng
    Kannan, Karuppiah
    Stump, Kate
    Rong, Yuanxin
    Shou, Yaping
    Nemunaitis, John J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
    Westin, Shannon Neville
    Smart, Melody L.
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Wheler, Jennifer J.
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Falchook, Gerald Steven
    Hong, David S.
    Zinner, Ralph
    Subbiah, Vivek
    Culotta, Kirk Salvatore
    Lu, Karen H.
    Coleman, Robert L.
    Kurzrock, Razelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [7] A phase 1b/2 study of ramucirumab in combination with emibetuzumab in patients with advanced solid tumors
    Bendell, Johanna
    Fuchs, Charles
    Voss, Martin
    Bauer, Todd M.
    Choueiri, Toni K.
    Drilon, Alexander
    Thorn, Katharine
    Wijayawardana, Sameera
    Moser, Brian
    Urunuela, Arantxa
    Wacheck, Volker
    Harding, James J.
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Phase I study of danusertib (D) in combination with bevacizumab (B) in solid tumors.
    Rosen, P. J.
    Tolcher, A. W.
    Lee, P.
    Smitley, M.
    Fuerst, M.
    Spinelli, R.
    Crippa, S.
    Jannuzzo, M. G.
    Comis, S.
    Papadopoulos, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Baldini, C.
    Danlos, F-X.
    Varga, A.
    Halse, H.
    Mouraud, S.
    Cassard, L.
    Bredel, D.
    Escriou, G.
    Parpaleix, A.
    Rafie, S.
    Abbassi, A. E.
    Laghouati, S.
    Farhane, S.
    Tselikas, L.
    Texier, M.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Massard, C.
    Marabelle, A.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S842 - S843
  • [10] An open-label phase 1b/2 study of surufatinib in combination with tislelizumab in subjects with advanced solid tumors.
    Dasari, Arvind
    Kauh, John S.
    Tucci, Christopher
    Nanda, Shivani
    Kania, Marek K.
    Carlisle, Jennifer W.
    Paulson, Andrew Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345